Skip to main content

Table 2 Articles included in the review

From: Carer burden in rare inherited diseases: a literature review and conceptual model

Title

Study design

Publication year

Disease (s) coded during thematic analysis

Type of carers

Relationship to patient (%)

Number of carers

Age

Countries

Concepts

Health state preference scores of children with spina bifida and their caregivers

Quantitative cross-sectional

2005

Spina bifida

Parents Grandparents

Mother (96%) Father/Grandmother (4%)

98

Mean (range):

37.7 (24–70)

NR

Well-being

Caring for the carers: quality of life in Huntington’s disease

Literature review

2005

Huntington’s disease

N/A

N/A

N/A

N/A

N/A

Practical

Support Systems

Well-being

The main problems of parents of a child with epidermolysis bullosa

Qualitative

2008

DDEB

EBS

EBS-DM

EBS-K

EBS-WC

JEB-nH

RDEB

RDEB-mut

Parents

Mother (64.7%)

Father (35.3%)

17

NR

Netherlands

Information

Practical

Social/Community

Well-being

Quality of life in patients with epidermolysis bullosa

Quantitative cross-sectional

2009

DDEB, generalised

DDEB, other subtypes

EBS-DM

EBS, localised

EBS, other subtypes

JEB-nH, generalised

KS

RDEB, generalised other

RDEB, other subtypes

RDEB, severe generalised

N/R

N/R

125

N/R

N/R

Social/Community

Well-being

Family burden in epidermolysis bullosa is high independent of disease type/subtype

Quantitative cross-sectional

2010

DDEB, generalised EBS-DM

EBS, localised

EBS, other subtypes

JEB n–H, generalised

RDEB, generalised other

RDEB, other subtypes RDEB, severe generalised

Parents

Mother (82.1%)

Father (17.9%)

28

Mean:

34.4

Italy

Disease Severity

Faith

Information

Practical

Social/Community,

Support Systems

Well-being

Factors affecting quality of life in epidermolysis bullosa

Literature review

2010

DDEB

EBS

JEB

RDEB

Parents

NR

NR

NR

NR

Information

Practical

Social/Community

Well-being

Caregiver’s burden and quality of life in mitochondrial disease

Quantitative cross-sectional

2010

Complex I defect

Parents

Mother (100%)

33

Mean (range):

37.72 (29–55)

Korea

Information

Practical

Well-being

The burden and quality of life of caregivers of sickle cell anemia patients taking hydroxyurea versus those not taking hydroxyurea

Quantitativecross-sectional

2012

Sickle cell anaemia

Parents

Mothers (81.1%)

Fathers (18.9%)

37

Mean (range):

42.95 (18–69)

Brazil

Practical

Well-being

Assessment of quality of life of parents of children with osteogenesis imperfecta

Quantitative cross-sectional

2012

Osteogenesis imperfecta types I, III, and IV

Parents

Mother (NR)

Father (NR)

25

Mothers, mean:

34.3

Fathers, mean:

38.1

Poland

Disease Severity

Practical

Social/Community

Support Systems

The experience of being a female carrier of haemophilia and the mother of a haemophilic child

Qualitative

2013

Haemophilia A

Haemophilia B

Parents

Mothers (100%)

13

Mean (range):

44 (28–83)

Sweden

Being a Carrier of Rare Disease

Carer Perceptions

Information

Practical

Social/Community

Support Systems

Quest for Knowledge

Well-being

Understanding the experience of caring for children with haemophilia: cross-sectional study of caregivers in the United States

Quantitative cross-sectional

2014

Haemophilia A

Haemophilia B

Parents

Other relatives

Mothers (88.39%)

Fathers (10.3%)

Grandparents or siblings (1.3%)

310

Age Category: mean (%)

18–34: 76 (24.5%)

35–44: 148 (47.7)

45–54: 82(26.5)

55–64: 4(1.3)

US

Disease Severity

Practical

Well-being

Shaping and managing the course of a child’s disease: parental

experiences with osteogenesis imperfecta

Qualitative

2014

Osteogenesis imperfecta

Parents

Mothers (70.83%)

Fathers (29.17%)

48

NR

Canada, US, Latin America, Europe

Acceptance

Being a Carrier of Rare Disease

Carer Perceptions Information

Practical

Social/Community

Well-being

Parents of children with haemophilia at an early age:

assessment of perceived stress and family functioning

Quantitative cross-sectional

2014

Haemophilia A

Haemophilia B

Parents

Mothers (53%)

Fathers (47%)

49

Mean:

38.86

Spain

Practical

Well-being

Haemophilia Experiences, Results and Opportunities (HERO) Study: influence of haemophilia on interpersonal relationships as reported by adults with haemophilia and parents of children with haemophilia

Quantitative cross-sectional

2014

Haemophilia A

Haemophilia B

Parents

Mothers (75.58)

Fathers (24.42%)

561

NR

Algeria, Argentina, Canada, China, France Germany, Italy, Spain,

UK, US

Being a Carrier of Rare Disease

Information Social/Community

Support Systems

Well-being

Difficulties experienced by caregivers of patients diagnosed with osteogenesis imperfecta (OI): example of a hospital

Mixed-methods

2015

Osteogenesis imperfecta

Parents

Mothers (93.5%)

Fathers (6.5%)

46

Mean:

35.52

Turkey

Carer Perceptions

Faith

Information

Practical

Quest for Knowledge

Social/Community

Support Networks

Well-being

Through the looking glass: an exploratory study of the lived experiences and unmet needs of families affected by Von Hippel–Lindau disease

Mixed-methods

2015

Von Hippel–Lindau disease

Parents

Partners

Mothers (62.5%)

Fathers (12.5%)

Partners (37.5%)

8

Mean (range):

57 (37–75)

Australia

Information

Practical

Social/Community

Support Systems

Well-being

Parenting a child with haemophilia while living in a non-metropolitan area

Qualitative

2015

Haemophilia A

Haemophilia B

Parents

Mothers (85.7%)

Fathers (14.3%)

7

Range:

25–48

Australia

Acceptance

Being a Carrier of Rare Disease

Carer Perceptions

Information

Practical

Quest for Knowledge Social/Community

Support Systems

Well-being

Mucopolysaccharidosis: caregiver quality of life

Quantitative cross-sectional

2015

MPS-I

MPS-II

MPS-III

MPS-IV

MPS-VI

Parents

Mothers (100%)

11

Mean (range):

35 (29–43)

Brazil

Practical

Social/Community

Well-being

A tortuous route to a capable fatherhood: the experience of being a father to a child with severe haemophilia

Qualitative

2015

Haemophilia A

Parents

Fathers (100%)

14

Mean (range):

43.5 (28–57)

Sweden

Acceptance

Carer Perceptions

Gratitude and Hope

Information

Practical

Social/Community

Well-being

Social/economic costs and health-related quality of life of mucopolysaccharidosis patients and their caregivers in Europe

Quantitative cross-sectional

2016

MPS-II (Hunter syndrome)

MPS-I-H/S (Hurler–Scheie syndrome)

MPS-I-H (Hurler syndrome)

MPS- VI (Maroteaux–Lamy syndrome)

MPS-IV, subtypes A and B (Morquio syndrome)

MPS- III, subtypes A, B, C, and

D (Sanfilippo syndrome)

MPS-I-S (Scheie syndrome)

MPS- VII (Sly syndrome)

Parents

Partners

Mothers (98.5%)

Partners (1.5%)

66

Mean:

39.6

Italy, Spain, Germany, France, Hungary, Sweden, Bulgaria

Practical

Parents’ experiences of living with, and caring for children, adolescents and young adults with mucopolysaccharidosis (MPS)

Qualitative

2016

MPS-I (Hurler syndrome, Scheie syndrome)

MPS-II (Hunter syndrome)

MPS-III (Sanfilipo syndrome)

MPS-VI (Maroteaux–Lamy syndrome)

Parents

NR

8

NR

Ireland

Acceptance

Carer Perceptions

Gratitude and Hope

Information

Practical

Social/Community

Well-being

Experiences of caregivers of children with inherited metabolic diseases: a qualitative study

Qualitative

2016

Carnitine uptake defect

Citrin deficiency

Galactosemia

Glutaric acidemia type I

Glycogen storage disease type 1

Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency

Maple syrup urine disease

Medium chain acyl-CoA dehydrogenase deficiency

MPS-I

Ornithine transcarbamylase deficiency

Phenylalanine hydroxylase deficiency

Tyrosinemia type I

Parents

Grandparents

Mothers (85.7%)

Fathers/Grandfathers (14.3%)

21

NR

Canada

Acceptance

Carer Perceptions

Establish a Routine

Information

Practical

Support Systems

Well-being

Difficulties in daily life and associated factors, and QoL of children with inherited metabolic disease and their parents in Japan: a literature review

Literature review

2016

AA

CD

HM

IEM

IMD

MPS

MSUD

PA

PKU

Parents

Mothers (NR)

Fathers (NR)

NA

NA

Japan

Carer Perceptions

Information

Practical

Social/Community

Support Systems

Well-being

Caregiver burden in haemophilia: results from a single UK centre

Quantitative cross-sectional

2017

Haemophilia A

Haemophilia B

Parents

Mothers (80%)

Fathers (20%)

20

Mothers, mean:

40.5

Fathers, mean:

42.5

UK

Practical

Social/Community

Well-being

The burden of bleeds and other clinical determinants on caregivers of children with haemophilia (the BBC Study)

Quantitative cross-sectional

2019

Haemophilia A

Haemophilia B

Parents

Mothers (81.35%)

144

Mean (range):

39.8 (24–57)

Germany, Italy, Netherlands, Poland, Sweden, Turkey, UK

Carer Perceptions

Disease Severity

Practical

Well-being

Psychosocial recommendations for the care of children and adults with epidermolysis bullosa and their family: evidence based guidelines

Literature review

2019

DDEB

EBS

EBS-I

JEB

KS

RDEB

RDEB + 

Family

NA

NR

NR

NR

Carer Perceptions

Information

Practical

Social/Community

Support Systems

Well-being

Pathway to diagnosis and burden of illness in mucopolysaccharidosis type VII – a European caregiver survey

Quantitative cross-sectional

2019

MPS-VII

Parents

NR

12

NR

Germany, Spain, Netherlands, Turkey

Carer Perceptions

Practical

Information

Support Systems

Emotional experience in parents of children with Zellweger spectrum disorders: a qualitative study

Qualitative

2019

Clinically similar peroxisome disorder

D-bifunctional protein deficiency

Zellweger spectrum disorder

Parents

Mothers (67.57%)

Fathers (32.43%)

37

Age Category: mean (%)

25–34: 8 (21.6)

35–44: 24 (64.9)

45–54: 3 (8.1)

55–64: 2 (5.4)

US (89.2%)

Outside US (10.8%)

Acceptance

Carer Perception

Gratitude and Hope

Information

Practical

Support Systems

Well-being

Assessing the supportive care needs of parents with a child with a bleeding disorder using the Parental Needs Scale for Rare Diseases (PNS-RD): A single-centre pilot study

Quantitative cross-sectional

2019

Factor II deficiency

Factor V deficiency

Factor VII deficiency

Haemophilia A (mild, moderate, severe)

Haemophilia B (mild, moderate, severe, factor X deficiency, fibrinogen deficiencies)

Bernard–Soulier syndrome

Glanzmann’s thrombasthenia

Hermansky–Pudlak syndrome

Inherited thrombocytopenia

Lowes syndrome

May–Hegglin syndrome

Platelet storage pool defects

Platelet release defects

Purpura

All other platelet defects

Thrombotic thrombocytopenia

Von Willebrand disease (type 1, type 2, type 3)

Parents

Mothers (56.9%)

Fathers (42.8%)

231

Age Category (%):

15–24: 1.3%

25–34: 8.3%

35–44: 55%

45–54: 31%

55 + : 4.4%

NR

Information

Practical

Well-being

An online survey on burden of illness among families with post-stem cell transplant mucopolysaccharidosis type I children in the United States

Quantitative cross-sectional

2019

MPS-I

Parents

NR

32

NR

US

Practical

Parental health spillover effects of paediatric rare genetic conditions

Quantitative case–control

2020

Brain malformations

Epileptic encephalopathies

Genetic kidney diseases

Mitochondrial diseases

Parents

Mothers (88%)

Fathers (12%)

207

Mean: 38.4

Australia

Practical

  1. AA = Argininosuccinic aciduria, CD = Citrin deficiency, DDEB = Dominant dystrophic epidermolysis bullosa, EBS = Epidermolysis bullosa simplex, EBS-DM = Epidermolysis bullosa simplex Dowling–Meara, EBS-K = Epidermolysis bullosa simplex Köbner type, EBS-WC = Epidermolysis bullosa simplex Weber–Cockayne, HM = Hypermethioninemia, IEM = Inborn error of metabolism, IMD = Inherited metabolic disease, JEB-nH = Junctional epidermolysis bullosa non-Herlitz type, KS = Kinder syndrome, MPS = Mucopolysaccharidosis, MPS-I = Mucopolysaccharidosis type I, MPS-I-H/S = Mucopolysaccharidosis type I Hurler–Scheie syndrome, MPS-I-H = Mucopolysaccharidosis type I Hurler syndrome, MPS-I-S = Mucopolysaccharidosis type I Scheie syndrome, MPS-II = Mucopolysaccharidosis type II, MPS-III = Mucopolysaccharidosis type III, MPS-IV = Mucopolysaccharidosis type IV, MPS-VI = Mucopolysaccharidosis type VI, MSUD = Maple syrup urine disease, PA = Propionic acidemia, PKU = Phenylketonuria, RDEB = Recessive dystrophic epidermolysis bullosa, RDEB-mut = Mutilating recessive dystrophic epidermolysis bullosa